Institutional Ownership Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO). We have compiled data on the 190 institutions that hold shares in the stock, with a total of 73.8 Million shares, which have been reported (via 13F filing form) to have a value of $1.65 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Sg Americas Securities, LLC
|
Jan 17, 2025 Q4 2024 |
597,993
shares
|
$14.4 Million
0.07% of portfolio
|
Q4 2024
Added 4022.1%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
584,584
shares
|
$14 Million
0.0% of portfolio
|
Q3 2024
Reduced 0.56%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
532,596
shares
|
$12.8 Million
0.0% of portfolio
|
Q3 2024
Reduced 4.01%
|
|
Emerald Advisers, LLC
|
Oct 29, 2024 Q3 2024 |
524,427
shares
|
$12.6 Million
0.63% of portfolio
|
Q3 2024
Added 1.78%
|
|
Jpmorgan Chase & CO
New York, NY |
Dec 26, 2024 Q3 2024 |
488,046
shares
|
$11.7 Million
0.0% of portfolio
|
Q3 2024
Reduced 10.0%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
448,070
shares
|
$10.8 Million
0.0% of portfolio
|
Q3 2024
Reduced 52.66%
|
|
University Of Wisconsin Foundation
Madison, WI |
Nov 13, 2024 Q3 2024 |
423,849
shares
|
$10.2 Million
7.93% of portfolio
|
Q2 2024
Added 13.76%
|
|
Emerald Mutual Fund Advisers Trust
|
Oct 29, 2024 Q3 2024 |
415,201
shares
|
$9.97 Million
0.67% of portfolio
|
Q3 2024
Reduced 2.28%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
392,544
shares
|
$9.42 Million
1.76% of portfolio
|
Q3 2024
Added 1.7%
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Nov 13, 2024 Q3 2024 |
343,729
shares
|
$8.25 Million
5.72% of portfolio
|
Q3 2024
Added 4.87%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
335,618
shares
|
$8.06 Million
0.0% of portfolio
|
Q3 2024
Added 2.94%
|
|
Woodline Partners LP
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
292,468
shares
|
$7.02 Million
0.08% of portfolio
|
Q3 2024
Added 45.92%
|
|
Simplify Asset Management Inc.
New York, NY |
Nov 12, 2024 Q3 2024 |
283,766
shares
|
$6.81 Million
0.43% of portfolio
|
Q3 2024
Added 15.59%
|
|
Schonfeld Strategic Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
278,323
shares
|
$6.68 Million
0.06% of portfolio
|
Q3 2024
Reduced 37.0%
|
|
Rheos Capital Works Inc.
|
Oct 16, 2024 Q3 2024 |
276,000
shares
|
$6.63 Million
0.41% of portfolio
|
Q3 2024
Added 27.78%
|
|
Fred Alger Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
269,601
shares
|
$6.47 Million
0.04% of portfolio
|
Q3 2024
Added 117.79%
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
217,564
shares
|
$5.22 Million
0.0% of portfolio
|
Q3 2024
Reduced 15.52%
|
|
Schroder Investment Management Group
London, X0 |
Nov 13, 2024 Q3 2024 |
184,432
shares
|
$4.43 Million
0.01% of portfolio
|
Q3 2024
Reduced 25.17%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
174,903
shares
|
$4.2 Million
0.0% of portfolio
|
Q2 2024
Added 20.74%
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
159,558
shares
|
$3.83 Million
0.0% of portfolio
|
Q3 2024
Reduced 39.15%
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
Nov 14, 2024 Q3 2024 |
155,044
shares
|
$3.72 Million
0.01% of portfolio
|
Q3 2024
Reduced 34.72%
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Nov 13, 2024 Q3 2024 |
155,000
shares
|
$3.72 Million
0.02% of portfolio
|
Q3 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
149,901
shares
|
$3.6 Million
0.0% of portfolio
|
Q3 2024
Reduced 62.06%
|
|
Pdt Partners, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
139,296
shares
|
$3.34 Million
0.39% of portfolio
|
Q2 2024
Added 11.93%
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
127,668
shares
|
$3.07 Million
0.0% of portfolio
|
Q3 2024
Added 127.91%
|